Livmarli 9.5 mg/mL oral solution
MRX-803
Approved small_molecule active
Quick answer
Livmarli 9.5 mg/mL oral solution for Progressive Familial Intrahepatic Cholestasis, Alagille syndrome is a Approved program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Progressive Familial Intrahepatic Cholestasis, Alagille syndrome
- Phase
- Approved
- Modality
- small_molecule
- Status
- active